Valuation: ALTEOGEN Inc.

Market Cap 15,213B 11.47B 10.29B 9.5B 8.62B 16.1B 1,089B 16.3B 114B 45.24B 571B 43.04B 42.12B 1,810B P/E 2026 *
49.2x
P/E 2027 * 38.2x
Enterprise Value 14.72B 11.09M 9.96M 9.19M 8.34M 15.58M 1.05B 15.77M 110M 43.77M 552M 41.64M 40.75M 1.75B EV / Sales 2026 *
30.2x
EV / Sales 2027 * 21.9x
Free-Float
74.44%
Yield 2026 *
0.19%
Yield 2027 * 0.25%
1 week-5.41%
Current month-14.15%
1 month-12.60%
3 months-8.96%
6 months-25.05%
Current year-36.81%
1 week 216,500
Extreme 216500
239,000
1 month 209,000
Extreme 209000
268,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 40,307.69
Extreme 40307.692307
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 25/12/2025
Director of Finance/CFO 61 27/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 12/05/2008
Director/Board Member 70 28/03/2021
Director/Board Member 61 27/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
21/05/25 Exercice

Chief Executive Officer

7,200 0.0135%
27/03/24 Sell 1,600,000 3.0182%
05/01/24 Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-5.41%-41.25%+373.42% 11.47B
+0.22%-0.14%+55.12%+128.82% 1,143B
+0.91%+3.61%+41.21%+84.57% 647B
-0.12%-0.93%+25.59%+106.14% 506B
-0.06%+2.33%+49.21%+67.82% 384B
+0.86%-4.37%+61.16%+37.93% 350B
-0.06%+1.80%+24.84%+53.75% 293B
-0.35%+1.62%+2.20%+26.65% 265B
+0.75%+2.05%+53.85%+71.25% 242B
+0.25%+1.64%+32.05%+107.62% 197B
Average +0.27%-0.14%+30.40%+105.80% 403.9B
Weighted average by Cap. +0.33%+0.68%+42.01%+89.27%

Financials

2026 *2027 *
Net sales 488B 368M 330M 305M 276M 516M 34.91B 523M 3.65B 1.45B 18.3B 1.38B 1.35B 58.03B 660B 498M 447M 412M 374M 699M 47.26B 707M 4.94B 1.96B 24.77B 1.87B 1.83B 78.55B
Net income 307B 231M 207M 192M 174M 325M 21.96B 329M 2.3B 912M 11.51B 868M 849M 36.49B 381B 287M 257M 238M 216M 403M 27.25B 408M 2.85B 1.13B 14.28B 1.08B 1.05B 45.3B
Net Debt -495B -373M -335M -309M -280M -524M -35.42B -530M -3.7B -1.47B -18.57B -1.4B -1.37B -58.87B -739B -557M -500M -462M -419M -782M -52.91B -792M -5.53B -2.2B -27.74B -2.09B -2.05B -87.95B
Projected Income Statement - Annual - ALTEOGEN Inc.
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
181
Date Price Change Volume
27/10/26 ₩218,500.00 0.00% 232,496
26/10/26 ₩218,500.00 -2.67% 163,623
23/10/26 ₩224,500.00 -2.81% 238,029
22/10/26 ₩231,000.00 -3.75% 179,162
21/10/26 ₩240,000.00 +3.90% 253,612
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - ALTEOGEN Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
218,500.00KRW
Average target price
405,512.82KRW
Spread / Average Target
+85.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ALTEOGEN Inc.
  1. Stock Market
  2. Stocks
  3. A196170 Stock